Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аутоиммунный полигландулярный синдром взрослых: молекулярно-генетические и клинические характеристики (лекция)
________________________________________________
Troshina E.A., Larina A.A., Terekhova M.A. Polyglandular autoimmune syndrome in adults: molecular genetic and clinical characteristics (lecture). Consilium Medicum. 2019; 21 (4): 91–96. DOI: 10.26442/20751753.2019.4.190361
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: аутоиммунный полигландулярный синдром, хроническая надпочечниковая недостаточность, аутоиммунный тиреоидит, сахарный диабет 1-го типа, гипопаратиреоз, гипотиреоз, главный комплекс гистосовместимости человека.
________________________________________________
Key words: polyglandular autoimmune syndrome, chronic adrenal insufficiency, autoimmune thyroiditis, diabetes mellitus type 1, hypoparathyroidism, hypothyroidism, human leukocyte antigens.
2. Gombos Z, Hermann R, Kiviniemi M et al. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur J Endocrinol 2007; 157: 757–61.
3. Hansen MP, Kahaly GJ. Autoimmune polyglandular syndromes Dtsch Med Wochenschr 2013; 138 (7): 319-26; quiz 327-8. DOI: 10.1055/s-0032-1327355
4. Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161 (1): 11–20.
5. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004; 137 (2): 225–33.
6. Diagnostic criteria in autoimmune diseases. Y Shoenfeld, R Cervera, ME Gershwin, eds. Humana Press, Totowa, NJ. 2008.
7. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction. Endocr Rev 2002; 23 (3): 327–64. https://doi.org/10.1210/edrv.23.3.0466
8. Betterle C, Volpato M, Greggio AN, Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 1996; 9 (1): 113–23.
9. Albergoni P, Gazzola MV, Slanzi E et al. HLA–DR and DQ associations with autoimmune Addison's disease in Italian patients. Genes Immunity 2003; 4 (1): S35.
10. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 9–33.
11. Golden B, Levin L, Ban Y et al. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 2005; 90 (8): 4904–11.
12. Kahaly GJ, Frommer L, Schuppan D. Celiac Disease and Glandular Autoimmunity. Nutrients 2018; 10 (7): 814. DOI: 10.3390/nu10070814
13. Fan KC, Yang TH, Huang YC. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol 2018; 28 (6): 750–63. DOI: 10.1684/ejd.2018.3449.
14. Vrijman C, Kroon MW, Limpens J et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol 2012; 167 (6): 1224–35. DOI: 10.1111/j.1365-2133
15. Klein J, Stato A. The HLA System. First of two Parts. N Engl J Med 2000; 343: 702–9.
16. Klein J, Stato A. The HLA System. Second of two Parts. N Engl J Med 2000; 343: 782–6.
17. Huang W, Connor E, Dela Rosa T et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the Autoimmune Polyglandular Syndrome, the Human Leukocyte Antigen DR4-DQB1*0302 haplotype is implicated only in beta-cells autoimmunity. J Clin Endocrinol Metab 1996; 81: 2259–63.
18. Erichsen M, Løvås K, Skinningsrud B et al. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. J Clin Endocrinol Metab 2009; 94 (12): 4882–90.
19. Flesch BK, Matheis N, Alt T et al. HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab 2014; 99 (1): E177-82. DOI: 10.1210/jc.2013-2852
20. Triolo TM, Baschal EE, Armstrong TK et al. Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 Diabetes. J Clin Endocrinol Metab 2009; 94 (11): 4517–23.
21. Huber A, Menconi F, Corathers S et al. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008; 29: 697–725.
22. Villano MJB, Huber AK, Greenberg DA et al. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab 2009; 94: 1458–66.
23. Houcken J, Degenhart C, Bender K et al. PTPN22 and CTLA-4 Polymorphisms Are Associated With Polyglandular Autoimmunity. J Clin Endocrinol Metab 2018; 103 (5): 1977–84. DOI: 10.1210/jc.2017-02577
24. Dultz G, Matheis N, Dittmar M et al. CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity. Horm Metab Res 2009; 41 (6): 426–9.
25. Skinningsrud B, Husebye ES, Gervin K et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Human Genetics 2008; 16: 977–82.
26. Никонова Т.В. Сахарный диабет 1 типа и латентный аутоиммунный диабет взрослых (LADA): клинические, иммуно-генетические и гормонально-метаболические аспекты. Автореф. дис. ... д-ра мед. наук. М., 2011.
[Nikonova T.V. Sakharnyi diabet 1 tipa i latentnyi autoimmunnyi diabet vzroslykh (LADA): klinicheskie, immuno-geneticheskie i gormonal'no-metabolicheskie aspekty. Avtoref. dis. ... d-ra med. nauk. Moscow, 2011 (in Russian).]
27. Owen CJ, Eden JA, Jennings CE et al. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006; 37 (1): 97–104.
28. Lopez ER, Lange B, Kahles H et al. Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II. BMC Med Genet
2008; 9: 65.
29. Lopez ER, Zwermann O, Segni M et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 2004; 151 (2): 193–7.
________________________________________________
1. Neufeld M, Blizzard RM. Polyglandular autoimmune diseases. In: Pinchera A, Doniach D, Fenzi GF, Baschieri L, ed. Symposium on Autoimmune Aspects of Endocrine Disorders. New York: Academic Press, 1980; p. 357–65.
2. Gombos Z, Hermann R, Kiviniemi M et al. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur J Endocrinol 2007; 157: 757–61.
3. Hansen MP, Kahaly GJ. Autoimmune polyglandular syndromes Dtsch Med Wochenschr 2013; 138 (7): 319-26; quiz 327-8. DOI: 10.1055/s-0032-1327355
4. Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161 (1): 11–20.
5. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004; 137 (2): 225–33.
6. Diagnostic criteria in autoimmune diseases. Y Shoenfeld, R Cervera, ME Gershwin, eds. Humana Press, Totowa, NJ. 2008.
7. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction. Endocr Rev 2002; 23 (3): 327–64. https://doi.org/10.1210/edrv.23.3.0466
8. Betterle C, Volpato M, Greggio AN, Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 1996; 9 (1): 113–23.
9. Albergoni P, Gazzola MV, Slanzi E et al. HLA–DR and DQ associations with autoimmune Addison's disease in Italian patients. Genes Immunity 2003; 4 (1): S35.
10. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 9–33.
11. Golden B, Levin L, Ban Y et al. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 2005; 90 (8): 4904–11.
12. Kahaly GJ, Frommer L, Schuppan D. Celiac Disease and Glandular Autoimmunity. Nutrients 2018; 10 (7): 814. DOI: 10.3390/nu10070814
13. Fan KC, Yang TH, Huang YC. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol 2018; 28 (6): 750–63. DOI: 10.1684/ejd.2018.3449.
14. Vrijman C, Kroon MW, Limpens J et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol 2012; 167 (6): 1224–35. DOI: 10.1111/j.1365-2133
15. Klein J, Stato A. The HLA System. First of two Parts. N Engl J Med 2000; 343: 702–9.
16. Klein J, Stato A. The HLA System. Second of two Parts. N Engl J Med 2000; 343: 782–6.
17. Huang W, Connor E, Dela Rosa T et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the Autoimmune Polyglandular Syndrome, the Human Leukocyte Antigen DR4-DQB1*0302 haplotype is implicated only in beta-cells autoimmunity. J Clin Endocrinol Metab 1996; 81: 2259–63.
18. Erichsen M, Løvås K, Skinningsrud B et al. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. J Clin Endocrinol Metab 2009; 94 (12): 4882–90.
19. Flesch BK, Matheis N, Alt T et al. HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab 2014; 99 (1): E177-82. DOI: 10.1210/jc.2013-2852
20. Triolo TM, Baschal EE, Armstrong TK et al. Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 Diabetes. J Clin Endocrinol Metab 2009; 94 (11): 4517–23.
21. Huber A, Menconi F, Corathers S et al. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008; 29: 697–725.
22. Villano MJB, Huber AK, Greenberg DA et al. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab 2009; 94: 1458–66.
23. Houcken J, Degenhart C, Bender K et al. PTPN22 and CTLA-4 Polymorphisms Are Associated With Polyglandular Autoimmunity. J Clin Endocrinol Metab 2018; 103 (5): 1977–84. DOI: 10.1210/jc.2017-02577
24. Dultz G, Matheis N, Dittmar M et al. CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity. Horm Metab Res 2009; 41 (6): 426–9.
25. Skinningsrud B, Husebye ES, Gervin K et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Human Genetics 2008; 16: 977–82.
26. Nikonova T.V. Sakharnyi diabet 1 tipa i latentnyi autoimmunnyi diabet vzroslykh (LADA): klinicheskie, immuno-geneticheskie i gormonal'no-metabolicheskie aspekty. Avtoref. dis. ... d-ra med. nauk. Moscow, 2011 (in Russian).
27. Owen CJ, Eden JA, Jennings CE et al. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006; 37 (1): 97–104.
28. Lopez ER, Lange B, Kahles H et al. Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II. BMC Med Genet
2008; 9: 65.
29. Lopez ER, Zwermann O, Segni M et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 2004; 151 (2): 193–7.
1 ФГБУ «Национальный медицинский исследовательский центр эндокринологии», Москва, Россия;
*troshina@inbox.ru
________________________________________________
1 Endocrinology Research Centre, Moscow, Russia;
*troshina@inbox.ru